Investments in intracardiac echocardiography (ICE) technologies highlight Medtronic's commitment to driving durable growth in the cardiac ablation business through a differentiated portfolio of techn
Medtronic beat Wall Street estimates for fourth-quarter revenue and adjusted profit on Wednesday, riding the wave of steady ​demand for its heart devices used in complex cardiac ‌procedures.
Disciplined execution and portfolio strength position Medtronic for continued momentum into fiscal year 2027 GALWAY, Ireland, June 3, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in
Medtronic (MDT) to report Q4 2026 results on 6/3, expected revenue of $9.61B and EPS of $1.55. Recent acquisition of SPR Therapeutics adds to neuromodulation business. Analyst ratings show mixed opini

Wall Street Week Ahead

08:21am, Sunday, 31'st May 2026
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
High energy prices have investors worried about a recession; these businesses should survive the hit just fine.

Medtronic: Cheap And Acquisitive

05:03pm, Friday, 29'th May 2026
Medtronic shares have declined ~25% since February amid sector headwinds and a disappointing MiniMed spin-off. Recent bolt-on acquisitions—SPR Therapeutics, CathWorks, and Scientia Vascular—signal
Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some
Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In the closing of the recent trading day, Medtronic (MDT) stood at $77.6, denoting a -1.27% move from the preceding trading day.
ISRG is widening its robotic surgery lead with faster growth, rising procedures and a recurring revenue model as Medtronic builds Hugo.

7 Dividend Stocks to Beat Inflation

01:22pm, Tuesday, 26'th May 2026
Historically, energy stocks have performed the best when inflation spikes.
Medtronic's Q4 results may get a lift from broad MedSurg growth, strong Cardiovascular demand and continued momentum in Diabetes.
Medtronic eyes a $650 million acquisition of SPR, adding the FDA-cleared SPRINT PNS System to expand its chronic pain treatment offerings ahead of the fiscal 2027 closing.

Future Dividend Kings - Part 1

10:40pm, Thursday, 21'st May 2026
The first list of 8 companies that could reach Dividend King status in coming years. These companies provide investors a wide range of starting dividend yields and growth histories. It's possible one
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE